Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER)
暂无分享,去创建一个
L. Myer | K. Fieggen | C. Stewart | M. Davies | A. Boulle | U. Mehta | A. Heekes | E. Kalk | A. Slogrove | N. Rhoda | J. Euvrard | A. Osman | G. Petro | M. Kroon | K. Anderson | F. Phelanyane | Stefan Gebhardt | Natasha Rhoda
[1] L. Myer,et al. Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment , 2022, BMC Pregnancy and Childbirth.
[2] D. Edwards,et al. Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent , 2021, Drug Safety.
[3] O. Khaliq,et al. An imperative to offer pregnant and lactating women access to the COVID-19 vaccination roll-out programme. , 2021, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[4] L. Holmes,et al. Limited surface examination to evaluate potential teratogens in a resource‐limited setting , 2021, Birth defects research.
[5] S. Madhi,et al. Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review , 2021, BMC Pregnancy and Childbirth.
[6] D. Bianchi,et al. Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines. , 2021, JAMA.
[7] G. Swamy,et al. Coronavirus disease 2019 vaccines in pregnancy , 2020, American journal of obstetrics & gynecology MFM.
[8] A. Boulle,et al. Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa , 2020, Drug Safety.
[9] L. Myer,et al. Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data , 2020, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.
[10] N. Tiffin,et al. Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa , 2019, International journal of population data science.
[11] G. Montepiedra,et al. Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women. , 2019, The New England journal of medicine.
[12] M. Hughes,et al. Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons , 2019, PLoS medicine.
[13] S. Lockman,et al. Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana. , 2019, The New England journal of medicine.
[14] H. Rees,et al. Why South Africa urgently needs to support the development of pregnancy exposure registries. , 2019, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[15] L. Myer,et al. Methods of gestational age assessment influence the observed association between antiretroviral therapy exposure, preterm delivery, and small-for-gestational age infants: a prospective study in Cape Town, South Africa. , 2018, Annals of epidemiology.
[16] A. Moosavi,et al. Prevalence and Reasons of Self-Medication in Pregnant Women: A Systematic Review and Meta-Analysis , 2018, International journal of community based nursing and midwifery.
[17] R. Shapiro,et al. Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception. , 2018, The New England journal of medicine.
[18] A. Boulle,et al. Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy , 2018, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[19] S. Andrade,et al. Administrative Claims Data Versus Augmented Pregnancy Data for the Study of Pharmaceutical Treatments in Pregnancy , 2017, Current Epidemiology Reports.
[20] Christian Hampp,et al. A systematic review of pregnancy exposure registries: examination of protocol‐specified pregnancy outcomes, target sample size, and comparator selection , 2017, Pharmacoepidemiology and drug safety.
[21] S. Kochhar,et al. Global alignment of immunization safety assessment in pregnancy - The GAIA project. , 2016, Vaccine.
[22] Wendy Watson,et al. Preterm birth: Case definition & guidelines for data collection, analysis, and presentation of immunisation safety data , 2016, Vaccine.
[23] C. Aldous,et al. South African congenital disorders data, 2006 - 2014. , 2016, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[24] L. Geerts,et al. A comparison of pregnancy dating methods commonly used in South Africa: a prospective study. , 2013, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[25] M. Petzold,et al. Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings , 2012, BMC Pregnancy and Childbirth.
[26] A. Gilbert,et al. Investigating outcomes associated with medication use during pregnancy: a review of methodological challenges and observational study designs. , 2012, Reproductive toxicology.
[27] Devon L. Greyson,et al. Prescription drug use during pregnancy in developed countries: a systematic review , 2011, Pharmacoepidemiology and drug safety.
[28] Candy Day,et al. Health and related indicators , 2007 .
[29] D. Wyszynski,et al. North American Antiepileptic Drug Pregnancy Registry , 2004, Epilepsia.
[30] A. Scheuerle,et al. Clinical review procedures for the Antiretroviral Pregnancy Registry , 2004, Pharmacoepidemiology and drug safety.
[31] Doris Ma Fat,et al. WHO Library Cataloguing-in-Publication Data , 2001 .